CalciMedica, Inc.·3

Jul 10, 5:36 PM ET

ALAFI CAPITAL CO LLC 3

3 · CalciMedica, Inc. · Filed Jul 10, 2026

Insider Transaction Report

Form 3
Period: 2026-06-25
Holdings
  • Common Stock

    5,112,345
  • Common Share Warrants

    [F1][F2]
    Exercise: $7.15Common Stock (130,651 underlying)
Footnotes (2)
  • [F1]The issue date of the warrants is July 22, 2025.
  • [F2]The expiration of these Warrants is the earlier of (i) 5:00pm (New York City time) on December 31, 2026 and (ii) 30 days following the Company's public disclosure of topline results from the Company's planned Phase 2 clinical trial in patients with acute kidney injury.
Signature
Christopher D. Alafi, as managing member of Alafi Capital Company, LLC|2026-07-10

Documents

1 file
  • 3
    form3.xmlPrimary

    FORM 3